Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT06004479
Other study ID # H-46721
Secondary ID 3092-51000-061-0
Status Active, not recruiting
Phase
First received
Last updated
Start date September 14, 2022
Est. completion date June 30, 2025

Study information

Verified date May 2024
Source Baylor College of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Before infants are born, they depend on their mother to provide the nutrients necessary to grow and develop, such as iron, folic acid, iodine and other vitamins and minerals. Pregnant people also rely on good nutrition to support their own health. In addition to essential nutrients, vitamins, and minerals, there are other natural components found in fruits and vegetables, called phytochemicals, that may support maternal and fetal health during pregnancy. While more is known about the role of phytochemicals in adult health, surprisingly little is known about phytochemical nutrition during pregnancy. This study focuses on a group of phytochemicals, called carotenoids, during pregnancy. The study will determine if and why levels of carotenoids in the body change across the course of pregnancy. Understanding carotenoid nutrition during pregnancy will improve the understanding ofnutrition needs of expectant mothers and their infants. To study these questions, both health pregnant and non-pregnant female adults will report on their dietary intake and participate in body measurements, health surveys, and carotenoid measurements of eyes, skin, and blood at time points corresponding with the first, second, and third trimesters of pregnancy as well as post-partum.


Description:

What a pregnant person eats is important for their own health and the health of their infant during pregnancy and after birth. Fruits and vegetables contain colorful substances called "carotenoids" which support the nutritional needs of the pregnant person and the infant, may fight inflammation, and may even benefit the person's memory and thinking ability. A person's carotenoid status can be measured with a blood sample and with optical measurements of the skin and eye. What isn't known, is if or why a pregnant person's carotenoid status changes over the course of pregnancy and the early post-partum period, and if those changes have consequences for pregnant person's and infant's health. The goal of this study is to better understand how and why body levels of carotenoids, change during pregnancy and the post-partum period. We will study whether these changes can be explained by pregnancy, a person's diet, and changes in body composition. We will study if changes in a female's carotenoid status are associated with changes in memory or thinking ability, levels of inflammation, and her infant's carotenoid levels. Ultimately, this information can guide nutrition advice for future pregnant people. This study involves 5 study visits for the pregnant or non-pregnant adult female participants with an option to enroll infants for the final, post-partum, visit. For the four follow-up visits, adult participants will have body measurements, will complete surveys, and will provide a blood sample. At the final visit, lactating participants will be asked to provide a milk sample. If enrolled, infant participants will provide an optional blood sample, have body measurements, have an optical skin measurement, and their participating adult guardian will complete an infant eating survey.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 40
Est. completion date June 30, 2025
Est. primary completion date June 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: Pregnant group - a pregnancy confirmed by positive pregnancy test and/or ultrasound - pre-pregnancy BMI 18.5-29.9 kg/m^2 - can speak, read, and understand English - agrees to take the prescribed daily prenatal multivitamin as recommended by their licensed prenatal healthcare provider throughout the study. Non-pregnant group - current BMI that is lean 18.5-29.9 kg/m^ - can speak, read, and understand English - agrees to continue taking any daily multivitamins or supplements throughout the study - consumes alcohol moderately as outlined by current guidelines. Infants - born at term (37 weeks gestation or more) - if infant was one of multiple births, only one sibling may be enrolled. Exclusion Criteria: - Metabolic, kidney, liver, digestive, or malabsorptive disorders with special dietary recommendations for the adult female or infant - currently uses tobacco, or drugs; consumes alcohol beyond current recommendations (zero in pregnancy, 1 drink daily average for non-pregnant) - adult female currently taking any isolated carotenoid supplements or high carotenoid (>2 mg/d) supplements - adult female currently consumes an exclusively vegan or vegetarian diet - adult female uses medications that interfere with dietary fat absorption - adult female has history of endocrine disorders requiring hormone administration (with the exception of medically managed hypothyroidism). - pregnant adult female has been informed by her doctor that she will need to take hormones during her pregnancy - adult female has current vision condition or disease that prevents them from seeing clearly regardless of corrective lenses. - adult female is currently lactating at enrollment.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Carotenoid Intake
Carotenoid intake assess by 24 hour dietary recalls
Serum carotenoid concentration
Serum total carotenoid concentration

Locations

Country Name City State
United States USDA/ARS Children's Nutrition Research Center, Baylor College of Medicine Houston Texas

Sponsors (2)

Lead Sponsor Collaborator
Baylor College of Medicine United States Department of Agriculture (USDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Subjective memory function (MAC-Q Score) - 1st Trimester Equivalent Subjective memory function assessed by MAC-Q 1st Trimester Equivalent: 8 weeks 0 days-13 weeks 6 days gestation(Week 0 if non-pregnant)
Other Subjective memory function (MAC-Q Score) - 2nd Trimester Equivalent Subjective memory function assessed by MAC-Q 2nd Trimester Equivalent: 22 weeks 0 days - 23 weeks 6 days gestation (or week 11-12 if non-pregnant)
Other Subjective memory function (MAC-Q Score) - 3rd Trimester Equivalent Subjective memory function assessed by MAC-Q 3rd Trimester Equivalent: 32 weeks 0 days - 33 weeks 6 days weeks gestation (week 22-23 if non-pregnant)
Other Subjective memory function (MAC-Q Score) - Post-partum Equivalent Subjective memory function assessed by MAC-Q Post-partum Equivalent: 7 weeks 0 days - 8 weeks 6 days post-partum (weeks 36-37 if non pregnant)
Other Serum IL-6 - 1st Trimester Equivalent Serum concentrations of IL-6 1st Trimester Equivalent: 8 weeks 0 days - 13 weeks 6 days gestation (Week 0 if non-pregnant)
Other Serum IL-6 - 2nd Trimester Equivalent Serum concentrations of IL-6 2nd Trimester Equivalent: 22 weeks 0 days-23 weeks 6 days gestation (or week 11-12 if non-pregnant)
Other Serum IL-6 - 3rd Trimester Equivalent Serum concentrations of IL-6 3rd Trimester Equivalent: 32 weeks 0 days-33 weeks 6 days gestation (week 22-23 if non-pregnant)
Other Serum IL-6 - Postpartum Equivalent Serum concentrations of IL-6 Post-partum Equivalent: 7 weeks 0 days - 8 weeks 6 days post-partum (weeks 36-37 if non pregnant)
Other Serum hsCRP - 1st Trimester Equivalent Serum concentrations of high sensitivity C-reactive protein 1st Trimester Equivalent: 8 weeks 0 days-13 weeks 6 days gestation (Week 0 if non-pregnant)
Other Serum hsCRP - 2nd Trimester Equivalent Serum concentrations of high sensitivity C-reactive protein 2nd Trimester Equivalent: 22w0d-23w6d gestation (or week 11-12 if non-pregnant)
Other Serum hsCRP - 3rd Trimester Equivalent Serum concentrations of high sensitivity C-reactive protein 3rd Trimester Equivalent: 32 weeks 0 days-33 weeks 6 days gestation (week 22-23 if non-pregnant)
Other Serum hsCRP - Postpartum Equivalent Serum concentrations of high sensitivity C-reactive protein Post-partum Equivalent: 7 weeks 0 days-8 weeks 6 days post-partum (weeks 36-37 if non pregnant)
Other Serum sTNFr-II - 1st Trimester Equivalent Serum concentrations of sTNFr-II 1st Trimester Equivalent: 8 weeks 0 days-13 weeks 6 days gestation (Week 0 if non-pregnant)
Other Serum sTNFr-II - 2nd Trimester Equivalent Serum concentrations of sTNFr-II 2nd Trimester Equivalent: 22 weeks 0 days-23 weeks 6 days gestation (or week 11-12 if non-pregnant)
Other Serum sTNFr-II - 3rd Trimester Equivalent Serum concentrations of sTNFr-II 3rd Trimester Equivalent: 32 weeks 0 days-33 weeks 6 days gestation (week 22-23 if non-pregnant)
Other Serum sTNFr-II - Post-partum Equivalent Serum concentrations of sTNFr-II Post-partum Equivalent: 7 weeks 0 days - 8 weeks 6 days post-partum (weeks 36-37 if non pregnant)
Other Serum TNF-alpha- 1st Trimester Equivalent Serum concentrations of sTNF-alpha 1st Trimester Equivalent: 8 weeks 0 days -13 weeks 6 days gestation (Week 0 if non-pregnant)
Other Serum TNF-alpha- 2nd Trimester Equivalent Serum concentrations of sTNF-alpha 2nd Trimester Equivalent: 22 weeks 0 days-23 weeks 6 days gestation (or week 11-12 if non-pregnant)
Other Serum TNF-alpha- 3rd Trimester Equivalent Serum concentrations of sTNF-alpha 3rd Trimester Equivalent: 32 weeks 0 days - 33 weeks 6 days gestation (week 22-23 if non-pregnant)
Other Serum TNF-alpha- Post-partum Equivalent Serum concentrations of sTNF-alpha Post-partum Equivalent: 7 weeks 0 days - 8 weeks 6 days post-partum (weeks 36-37 if non pregnant)
Other Infant serum carotenoid concentration Serum total carotenoid concentration in 7-8 week old infants 7 weeks 0 days - 8 weeks 6 days post-partum
Other Infant serum carotenoid concentration Serum total carotenoid concentration in 7-8 week old infants Post-partum: 7 weeks 0 days - 8 weeks 6 days post-partum
Primary Serum Total Carotenoid Concentrations - 1st Trimester Equivalent Sum of all major carotenoid species in serum collected from fasting participant. 1st Trimester Equivalent: 8 weeks 0 days-13 weeks 6 days gestation (Week 0 if non-pregnant)
Primary Serum Total Carotenoid Concentrations - 2nd Trimester Equivalent Sum of all major carotenoid species in serum collected from fasting participant. 2nd Trimester Equivalent: 22 weeks 0 days-23 weeks 6 days gestation (or week 11-12 if non-pregnant)
Primary Serum Total Carotenoid Concentrations - 3rd Trimester Equivalent Sum of all major carotenoid species in serum collected from fasting participant. 3rd Trimester Equivalent: 32 weeks 0 days -33 weeks 6 days weeks gestation (week 22-23 if non-pregnant)
Primary Serum Total Carotenoid Concentrations - Post-partum Sum of all major carotenoid species in serum collected from fasting participant. Post-partum Equivalent: 7 weeks 0 days - 8 weeks 6 days post-partum (weeks 36-37 if non pregnant)
Secondary Skin Carotenoid Concentrations - 1st Trimester Equivalent Skin carotenoid score measured by pressure-mediated reflection spectroscopy 1st Trimester Equivalent: 8 weeks 0 days -13 weeks 6 days gestation (Week 0 if non-pregnant)
Secondary Macular pigment optical density - 1st Trimester Equivalent Macular pigment optical density measured by heterochromatic flicker photometry 1st Trimester Equivalent: 8 weeks 0 days - 13 weeks 6 days gestation (Week 0 if non-pregnant)
Secondary Skin Carotenoid Concentrations - 2nd Trimester Equivalent Skin carotenoid score measured by pressure-mediated reflection spectroscopy 2nd Trimester Equivalent: 22 weeks 0d - 23 weeks 6 days gestation (or week 11-12 if non-pregnant)
Secondary Macular pigment optical density - 2nd Trimester Equivalent Macular pigment optical density measured by heterochromatic flicker photometry 2nd Trimester Equivalent: 22 weeks 0 days - 23 weeks 6 days gestation (or week 11-12 if non-pregnant)
Secondary Skin Carotenoid Concentrations - 3rd Trimester Equivalent Skin carotenoid score measured by pressure-mediated reflection spectroscopy 3rd Trimester Equivalent: 32 weeks 0 days - 33 weeks 6 days weeks gestation (week 22-23 if non-pregnant)
Secondary Macular pigment optical density - 3rd Trimester Equivalent Macular pigment optical density measured by heterochromatic flicker photometry 3rd Trimester Equivalent: 32 weeks 0 days -33 weeks 6 days weeks gestation (week 22-23 if non-pregnant)
Secondary Skin Carotenoid Concentrations - Post-partum Equivalent Skin carotenoid score measured by pressure-mediated reflection spectroscopy Post-partum Equivalent: 7 weeks 0 days - 8 weeks 6 days post-partum (weeks 36-37 if non pregnant)
Secondary Macular pigment optical density - Post-partum Equivalent Macular pigment optical density measured by heterochromatic flicker photometry Post-partum Equivalent: 7 weeks 0 days - 8 weeks 6 days post-partum (weeks 36-37 if non pregnant)
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3